Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AFFIRM: A Phase 2 Randomized, Placebo-Controlled Study of Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women

NCT03430037 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03430037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03430037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AFFIRM: A Phase 2 Randomized, Placebo-Controlled Study of Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
February 6, 2018
Completion date
November 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frail elderly syndrome